Glenmark Pharmaceuticals has updated its key managerial personnel authorized to determine material events and handle disclosures. The designated officials include Chairman & MD Glenn Saldanha, Executive Director Cherylann Pinto, Executive Director & CFO Anurag Mantri, and Company Secretary Harish Kuber. This clarification aims to streamline governance and improve communication with stock exchanges.